Author Vogelgsang, Jonathan

1 to 20 of 34 Items
  • 2018 Journal Article
    ​ ​Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort​
    Vogelgsang, J.; Wolff-Menzler, C.; Kis, B.; Abdel-Hamid, M.; Wiltfang, J. & Hessmann, P.​ (2018) 
    Psychogeriatrics18(5) pp. 393​-401​.​ DOI: https://doi.org/10.1111/psyg.12338 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Multiplex immunoassay measurement of amyloid-β42 to amyloid-β40 ratio in plasma discriminates between dementia due to Alzheimer’s disease and dementia not due to Alzheimer’s disease​
    Vogelgsang, J.; Shahpasand-Kroner, H.; Vogelgsang, R.; Streit, F. ; Vukovich, R. & Wiltfang, J. ​ (2018) 
    Experimental Brain Research236(5) pp. 1241​-1250​.​ DOI: https://doi.org/10.1007/s00221-018-5210-x 
    Details  DOI 
  • 2018 Book Chapter
    ​ ​Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-β in Human Blood Plasma​
    Vogelgsang, J.; Wiltfang, J.& Klafki, H. W.​ (2018)
    In:​Perneczky, Robert​ (Ed.), Methods in Molecular Biology Biomarkers for Alzheimer’s Disease Drug Development pp. 111​-124. ​New York, NY: ​Springer New York. DOI: https://doi.org/10.1007/978-1-4939-7704-8_7 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Reproducibility of Alzheimer’s Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions​
    Vogelgsang, J.; Wedekind, D. ; Bouter, C. ; Klafki, H.-W.   & Wiltfang, J. ​ (2018) 
    Journal of Alzheimer's Disease62(1) pp. 203​-212​.​ DOI: https://doi.org/10.3233/JAD-170793 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer’s disease​
    Lewczuk, P.; Gaignaux, A.; Kofanova, O.; Ermann, N.; Betsou, F.; Brandner, S. & Mroczko, B. et al.​ (2018) 
    Alzheimer's Research & Therapy10(1) art. 87​.​ DOI: https://doi.org/10.1186/s13195-018-0418-3 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease​
    Shahpasand-Kroner, H.; Klafki, H.-W.; Bauer, C.; Schuchhardt, J.; Hüttenrauch, M.; Stazi, M. & Bouter, C. et al.​ (2018) 
    Alzheimer's Research & Therapy10(1) art. 121​.​ DOI: https://doi.org/10.1186/s13195-018-0448-x 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Neue Biomarker für die Alzheimer-Krankheit in Liquor und Blut​
    Vogelgsang, J. & Wiltfang, J. ​ (2019) 
    Der Nervenarzt90(9) pp. 907​-913​.​ DOI: https://doi.org/10.1007/s00115-019-0772-9 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease​
    Santos, J. R. F.; Bauer, C.; Schuchhardt, J.; Wedekind, D. ; Waniek, K.; Lachmann, I. & Wiltfang, J.  et al.​ (2019) 
    Journal of Neural Transmission126(3) pp. 339​-348​.​ DOI: https://doi.org/10.1007/s00702-019-01982-5 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Prevalence of affective disorders and dementia in inflammatory polyarthropathies​
    Vogelgsang, J.; Heßmann, P. ; Wolff-Menzler, C. ; Gyßer, S.; Müller, G. A.   & Wiltfang, J. ​ (2019) 
    European Archives of Psychiatry and Clinical Neuroscience270(2) pp. 247​-252​.​ DOI: https://doi.org/10.1007/s00406-019-01015-y 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Comparison between amyloid-PET and CSF amyloid-β biomarkers in a clinical cohort with memory deficits​
    Bouter, C. ; Vogelgsang, J. & Wiltfang, J. ​ (2019) 
    Clinica Chimica Acta492 pp. 62​-68​.​ DOI: https://doi.org/10.1016/j.cca.2019.02.005 
    Details  DOI 
  • 2019 Journal Article
    ​ ​CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease​
    Teuber-Hanselmann, S.; Rekowski, J.; Vogelgsang, J.; von Arnim, C. ; Reetz, K.; Stang, A. & Jöckel, K.-H. et al.​ (2019) 
    Journal of Neurology, Neurosurgery & Psychiatry91(1) pp. 40​-48​.​ DOI: https://doi.org/10.1136/jnnp-2019-321073 
    Details  DOI 
  • 2019 Journal Article
    ​ ​P.239 Electroconvulsive therapy and the brain: no increase of neurofilament light chain in the treatment course​
    Zilles, D. ; Besse, M. ; Folsche, T.; Methfessel, I. ; Belz, M. ; Vogelgsang, J. & Wiltfang, J. ​ (2019) 
    European Neuropsychopharmacology29 pp. S183​-S184​.​ DOI: https://doi.org/10.1016/j.euroneuro.2019.09.281 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Nuclear medical imaging as part of dementia diagnostics in psychiatric day-care clinics and inpatient care settings​
    Vogelgsang, J.; Kis, B. ; Radenbach, K. ; Wolff-Menzler, C. ; Mavridou, K.; Timäus, C. & Gyßer, S. et al.​ (2019) 
    Aging clinical and experimental research32(5) pp. 809​-815​.​ DOI: https://doi.org/10.1007/s40520-019-01257-9 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Claims Data Analysis on the Dispensing of Tricyclic Antidepressants Among Patients With Dementia in Germany​
    Hessmann, P. ; Zeidler, J.; Stahmeyer, J.; Eberhard, S.; Vogelgsang, J.; Abdel-Hamid, M.   & Wolff-Menzler, C.  et al.​ (2019) 
    Frontiers in Pharmacology10.​ DOI: https://doi.org/10.3389/fphar.2019.00841 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer’s Disease Biomarkers in Cerebrospinal Fluid​
    Vogelgsang, J.; Vukovich, R.; Wedekind, D. & Wiltfang, J.​ (2019) 
    ASN Neuro11 pp. 1​-8​.​ DOI: https://doi.org/10.1177/1759091419845524 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article
    ​ ​To Be Continued? Long-Term Treatment Effects ofAntidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia​
    Bartels, C. ; Belz, M. ; Vogelgsang, J.; Hessmann, P. ; Bohlken, J.; Wiltfang, J.   & Kostev, K.​ (2020) 
    The Journal of Clinical Psychiatry81(5).​ DOI: https://doi.org/10.4088/JCP.19m13205 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer’s Disease Discrimination: A Pilot Study​
    Soares Martins, T.; Magalhães, S.; Rosa, I. M.; Vogelgsang, J.; Wiltfang, J. ; Delgadillo, I. & Catita, J. et al.​ (2020) 
    Journal of Alzheimer's Disease74(1) pp. 391​-405​.​ DOI: https://doi.org/10.3233/JAD-191034 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Serum neurofilament light chain (NFL) remains unchanged during electroconvulsive therapy​
    Besse, M. ; Belz, M. ; Folsche, T.; Vogelgsang, J.; Methfessel, I. ; Steinacker, P.   & Otto, M.  et al.​ (2020) 
    The World Journal of Biological Psychiatry21(2) pp. 148​-154​.​ DOI: https://doi.org/10.1080/15622975.2019.1702717 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach​
    Hansen, N.; Lipp, M.; Vogelgsang, J.; Vukovich, R.; Zindler, T.; Luedecke, D. & Gingele, S. et al.​ (2020) 
    Brain, Behavior, & Immunity - Health9 art. S2666354620301198​.​ DOI: https://doi.org/10.1016/j.bbih.2020.100154 
    Details  DOI 
  • 2020 Journal Article
    ​ ​Pre-Analytical Sampling and Storage Conditions of Amyloid-β Peptides in Venous and Capillary Blood​
    Walter, M.; Wiltfang, J.   & Vogelgsang, J.​ (2020) 
    Journal of Alzheimer's Disease78(2) pp. 529​-535​.​ DOI: https://doi.org/10.3233/JAD-200777 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page